dm+d

Unassigned

New Medicines

AcorafloxacinSkin and skin structure infections, acute bacterial SSTIs

Information

Acorafloxacin
New molecular entity
Furiex Pharmaceuticals
Furiex Pharmaceuticals

Development and Regulatory status

Discontinued
Discontinued
Discontinued
Jul 15: Development discontinued [1].

Category

Fluroquinolone which inhibits MuRF enzyme, required for cell wall synthesis
Skin and skin structure infections, acute bacterial SSTIs
Oral